Product Description: CIGB-300 (P15-Tat) is an anti-casein kinase 2 (CK2) peptide that exhibits anticancer properties by interfering with the phosphorylation of protein kinase CK2. CIGB-300 induces apoptosis in multiple tumor cell lines and can be used in cancer therapy research[1].
Formula: C127H215N53O30S3
References: [1]Perea S E, et al. CIGB-300, a novel proapoptotic peptide that impairs the CK2 phosphorylation and exhibits anticancer properties both in vitro and in vivo[J]. Molecular and cellular biochemistry, 2008, 316: 163-167.
CAS Number: 1072877-99-6
Molecular Weight: 3060.60
Research Area: Cancer
Target: Casein Kinase